Svenja Schneider

60 posts

Svenja Schneider banner
Svenja Schneider

Svenja Schneider

@SSchneiderMD

PGY-6 Cardiology Fellow @TJHeartFellows

Katılım Mart 2022
285 Takip Edilen159 Takipçiler
Svenja Schneider retweetledi
Jefferson Cardiology Fellows
Jefferson Cardiology Fellows@TJHeartFellows·
Congratulations to Dr. Yash Varma on being selected as our 2025-2026 Louis R. Dinon M.D. Chief Cardiology fellow!
Jefferson Cardiology Fellows tweet media
English
0
2
15
1.2K
Svenja Schneider retweetledi
David H. Wiener, MD
David H. Wiener, MD@DavidWienerMD·
Four @TJUHospital posters at #ASE2025. Shown: faculty colleague Andrew Peters, MD and Zach Conley MS3; @TJHeartFellows Svenja Schneider, MD and Yash Varma, MD. Last: the special privilege I had of authoring one with my son, 3rd year fellow Josh Wiener, MD @ASE360
David H. Wiener, MD tweet mediaDavid H. Wiener, MD tweet mediaDavid H. Wiener, MD tweet mediaDavid H. Wiener, MD tweet media
English
2
5
25
2K
Svenja Schneider retweetledi
David H. Wiener, MD
David H. Wiener, MD@DavidWienerMD·
We welcome @SharonneHayes to @TJUHospital as tomorrow's Dinon lecturer, speaking on advancing women in cardiology. A fun opportunity tonight for our ♀️ fellows, faculty and senior adminstrators to meet informally with Dr. Hayes at a delicious dinner at @vedgerestaurant
David H. Wiener, MD tweet mediaDavid H. Wiener, MD tweet media
English
0
1
17
817
Svenja Schneider retweetledi
Houston Shock Symposium
Houston Shock Symposium@HoustonShockHSS·
📣NEW THIS YEAR! The @HoustonShockHSS introduces Shock Jeopardy: a dynamic, interactive session where participants test knowledge, compete, & enhance understanding of shock topics in a fun, challenging format, combining education with excitement. Join us on 3/24 at 6:30 PM #HSS24
Houston Shock Symposium tweet mediaHouston Shock Symposium tweet mediaHouston Shock Symposium tweet mediaHouston Shock Symposium tweet media
English
0
9
23
12.4K
Svenja Schneider retweetledi
NEJM
NEJM@NEJM·
In patients with transthyretin amyloid cardiomyopathy, the TTR stabilizer acoramidis resulted in a better primary hierarchical outcome (including mortality, morbidity, and function) than placebo. Read the full ATTRibute-CM trial results: nej.md/48tEoTH
English
1
51
163
44K
Svenja Schneider retweetledi
Jefferson Cardiology Fellows
Jefferson Cardiology Fellows@TJHeartFellows·
First year fellow profile! Svenja Schneider, MD Residency: Jefferson Med School: Drexel Hobbies: hiking with my dog Cooper, traveling, and playing ultimate frisbee Cardiology Interests: noninvasive cardiology, CV outcomes, health disparities, medical education @SSchneiderMD
Jefferson Cardiology Fellows tweet media
English
0
3
19
1.3K